Similar articles

• Sporadic and neurofibromatosis type 2-associated meningioma in children and adolescents.

  Wagener K, Beckhaus J, Boekhoff S, Friedrich C, Müller HL. Wagener K, et al. J Neurooncol. 2023 Jul;163(3):555-563. doi: 10.1007/s11060-023-04344-0. Epub 2023 Jul 4. J Neurooncol. 2023. PMID: 37402092
• Molecular genetic investigation of the neurofibromatosis type 2 tumor suppressor gene in sporadic meningioma.

  Harada T, Irving RM, Xuereb JH, Barton DE, Hardy DG, Moffat DA, Maher ER. Harada T, et al. J Neurosurg. 1996 May;84(5):847-51. doi: 10.3171/jns.1996.84.5.0847. J Neurosurg. 1996. PMID: 8622160
• Meningioangiomatosis is associated with neurofibromatosis 2 but not with somatic alterations of the NF2 gene.

  Stemmer-Rachamimov AO, Horgan MA, Taratuto AL, Munoz DG, Smith TW, Frosch MP, Louis DN. Stemmer-Rachamimov AO, et al. J Neuropathol Exp Neurol. 1997 May;56(5):485-9. doi: 10.1097/00005072-199705000-00004. J Neuropathol Exp Neurol. 1997. PMID: 9143261 Review.
• Neurofibromatosis type 2 gene mutation and progesterone receptor messenger RNA expression in the pathogenesis of sporadic orbitocranial meningioma.

  Supartoto A, Mahayana IT, Heriyanto DS, Sasongko MB, Respatika HD, Sakti DH, Nurlaila PS, Kusnanto H, Pawiroranu S, Haryana SM. Supartoto A, et al. Int J Ophthalmol. 2019 Apr 18;12(4):571-576. doi: 10.18240/ijo.2019.04.07. eCollection 2019. Int J Ophthalmol. 2019. PMID: 31024808 Free PMC article.
• Meningiomas in children and adolescents: a meta-analysis of individual patient data.

  Kotecha RS, Pascoe EM, Rushing EJ, Rorke-Adams LB, Zwerdling T, Gao X, Li X, Greene S, Amirjamshidi A, Kim SK, Lima MA, Hung PC, Lakhdar F, Mehta N, Liu Y, Devi BI, Sudhir BJ, Lund-Johansen M, Gjerris F, Cole CH, Gottardo NG. Kotecha RS, et al. Lancet Oncol. 2011 Dec;12(13):1229-39. doi: 10.1016/S1470-2045(11)70275-3. Epub 2011 Nov 15. Lancet Oncol. 2011. PMID: 22094004 Review.